Insider · CIK 0001572857

Cheung Sylvia

Reports to the SEC for 1 company · BEDFORD, MA

sec.gov

Transactions

Companies

Filings

CIK

0001572857

Forms 4 and 5

Insider transactions

35 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2020-02-26	ANIKAnika Therapeutics, Inc.F Tax Payment	Chief Financial Officer	FTax Payment	−881 sh	$42.25	−$37.2K	49,281
2020-02-26	ANIKAnika Therapeutics, Inc.A Award	Chief Financial Officer	AAward	+3,000 sh	—	—	50,162
2020-02-25	ANIKAnika Therapeutics, Inc. · Restricted Stock UnitA Award	Chief Financial Officer	AAward	+11.7K sh	—	—	11,700
2020-02-04	ANIKAnika Therapeutics, Inc.F Tax Payment	Chief Financial Officer	FTax Payment	−579 sh	$40.59	−$23.5K	47,162
2019-11-08	ANIKAnika Therapeutics, Inc.S Sale	Chief Financial Officer	SSale	−20K sh	$59.71	−$1.19M	47,741
2019-11-06	ANIKAnika Therapeutics, Inc. · Stock Appreciation RightsM Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	−35K sh	—	—	0
2019-11-06	ANIKAnika Therapeutics, Inc.M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	+35K sh	$6.36	+$223K	71,422
2019-11-06	ANIKAnika Therapeutics, Inc.F Tax Payment	Chief Financial Officer	FTax Payment	−3,681 sh	$60.48	−$223K	67,741
2019-02-27	ANIKAnika Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Chief Financial Officer	AAward	+7,609 sh	—	—	7,609
2019-02-26	ANIKAnika Therapeutics, Inc. · Restricted Stock UnitA Award	Chief Financial Officer	AAward	+9,000 sh	—	—	9,000
2019-02-04	ANIKAnika Therapeutics, Inc.F Tax Payment	Chief Financial Officer	FTax Payment	−607 sh	$38.10	−$23.1K	36,422
2019-02-03	ANIKAnika Therapeutics, Inc.F Tax Payment	Chief Financial Officer	FTax Payment	−579 sh	$37.97	−$22K	37,029
2018-03-02	ANIKAnika Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Chief Financial Officer	AAward	+7,788 sh	—	—	7,788
2018-01-24	ANIKAnika Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Chief Financial Officer	AAward	+21.4K sh	—	—	21,400
2017-02-24	ANIKAnika Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Chief Financial Officer	AAward	+11.5K sh	—	—	11,500
2017-02-22	ANIKAnika Therapeutics, Inc.S Sale	Chief Financial Officer	SSale	−1,193 sh	$49.05	−$58.5K	38,415
2017-02-22	ANIKAnika Therapeutics, Inc.S Sale	Chief Financial Officer	SSale	−807 sh	$49.02	−$39.6K	37,608
2017-02-22	ANIKAnika Therapeutics, Inc. · Stock Appreciation RightsM Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	−5,000 sh	—	—	0
2017-02-22	ANIKAnika Therapeutics, Inc. · Stock Option (Right to buy)M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	−4,193 sh	—	—	20,000
2017-02-22	ANIKAnika Therapeutics, Inc. · Stock Option (Right to buy)M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	−807 sh	—	—	0
2017-02-22	ANIKAnika Therapeutics, Inc.M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	+5,000 sh	$6.99	+$35K	39,608
2017-02-22	ANIKAnika Therapeutics, Inc.M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	+5,000 sh	$10.99	+$55K	37,725
2017-02-22	ANIKAnika Therapeutics, Inc.S Sale	Chief Financial Officer	SSale	−2,000 sh	$49.01	−$98K	34,608
2017-02-22	ANIKAnika Therapeutics, Inc.F Tax Payment	Chief Financial Officer	FTax Payment	−1,117 sh	$49.20	−$55K	36,608
2017-01-27	ANIKAnika Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Chief Financial Officer	AAward	+28.5K sh	—	—	28,500
2016-02-24	ANIKAnika Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Chief Financial Officer	AAward	+3,325 sh	—	—	3,325
2016-02-04	ANIKAnika Therapeutics, Inc.A Award	Chief Financial Officer	AAward	+7,900 sh	—	—	32,725
2016-02-04	ANIKAnika Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Chief Financial Officer	AAward	+18.3K sh	—	—	18,300
2015-07-31	ANIKAnika Therapeutics, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	+5,000 sh	—	—	0
2015-07-31	ANIKAnika Therapeutics, Inc.M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	+5,000 sh	$12.61	+$63.1K	24,825
2015-02-03	ANIKAnika Therapeutics, Inc.A Award	Chief Financial Officer	AAward	+6,675 sh	—	—	19,825
2015-02-03	ANIKAnika Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Chief Financial Officer	AAward	+4,600 sh	—	—	4,600
2015-02-03	ANIKAnika Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Chief Financial Officer	AAward	+13.7K sh	—	—	13,700
2014-01-27	ANIKAnika Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Chief Financial Officer	AAward	+13.8K sh	—	—	13,800
2014-01-27	ANIKAnika Therapeutics, Inc.A Award	Chief Financial Officer	AAward	+6,100 sh	—	—	13,150

Recent filings

Accepted (ET)
Feb 274
Cheung Sylvia0001171843-20-001358
SEC(opens sec.gov)
Feb 64
Cheung Sylvia0001171843-20-000783
SEC(opens sec.gov)
Nov 84
Cheung Sylvia0001171843-19-007390
SEC(opens sec.gov)
Feb 284
Cheung Sylvia0001171843-19-001385
SEC(opens sec.gov)
Feb 64
Cheung Sylvia0001171843-19-000756
SEC(opens sec.gov)
Mar 24
Cheung Sylvia0001171843-18-001658
SEC(opens sec.gov)
Jan 264
Cheung Sylvia0001171843-18-000689
SEC(opens sec.gov)
Feb 284
Anika Therapeutics, Inc.0001171843-17-001206
SEC(opens sec.gov)
Feb 244
Anika Therapeutics, Inc.0001171843-17-001108
SEC(opens sec.gov)

Companies

Anika Therapeutics, Inc.Chief Financial OfficerANIK

Address

32 WIGGINS AVENUE

BEDFORD, MA, 01730